Exposure to Mosquito-Transmitted Dengue May Provide Immunity Against COVID-19
A study has found a link between the spread of the SARS-CoV-2 virus and previous outbreaks of dengue fever in Brazil, suggesting that exposure to the mosquito-transmitted illness could provide some immunity against COVID-19. More...25 Sep 2020
New Test Developed with Simplified Buffer Formations Enables Fast, Cheap and Accurate COVID-19 Diagnosis
A new method developed for fast, cheap, yet accurate testing for COVID-19 infection simplifies and frees the testing from expensive reaction steps, enabling upscaling of the diagnostics and making it particularly attractive for places and situations with limited resources, for repeated testing and for moving resources from expensive diagnostics to other parts of the care chain. More...24 Sep 2020
Four-in-One Test Kit for Detecting Influenza A, Influenza B, RSV and SARS-CoV-2 Set to Launch in November
A new four-in-one test kit for detecting influenza A, influenza B, RSV and SARS-CoV-2 is set to be launched in the coming month of November before the flu season begins in the Northern hemisphere. More...24 Sep 2020
FDA to Issue Stricter Guidance for Emergency Authorization of COVID-19 Vaccine
The US Food and Drug Administration (FDA Silver Spring, MD, USA) is reportedly planning to announce new tougher standards for an emergency authorization of a COVID-19 vaccine in an effort to boost transparency and public trust. More...24 Sep 2020
Johnson & Johnson Begins Phase 3 Trial of One-Dose COVID-19 Vaccine Candidate
Johnson & Johnson (New Brunswick, NJ, USA) has launched its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies (Beerse, Belgium). More...24 Sep 2020
New
Gold Member
X-Ray QA Meter
T3 AD Pro
Gold Member
12-Channel ECG
CM1200B
New
In-Bed Scale
IBFL500
New
Mobile Barrier
Tilted Mobile Leaded Barrier
In Other News
Fujifilm to Seek Approval for Anti-Influenza Drug to Treat COVID-19 Patients After Positive Phase 3 Trial Results
Virus-Fighting Enzymes in Bacteria Could Lead to Development of Highly Effective Antiviral Drugs Against COVID-19
Global COVID-19 Test Kits Market to Surpass USD 13 Billion by 2026
GK Pharmaceuticals Accu-Right SARS-CoV-2 RT-PCR Kit Granted FDA Emergency Use Authorization
New Patented Technology Determines Who Should Receive COVID-19 Vaccine First by Tracing Coronavirus “Super Distributors”
New Study Finds Natural and Vaccine-Induced Immunity Will Shape Future Trajectory of Coronavirus Pandemic
COVID-19 Study Finds High Rates of Unexplained Strokes and Delayed Recognition of Symptoms
World's First Patient-Controlled Nasopharyngeal Swab Robot for COVID-19 Testing Reduces Risk of Exposure to SARS-CoV-2
Druggable Pocket Discovered In SARS-CoV-2 Spike Protein Could Stop Coronavirus in Its Tracks
New Assay That Mimics How SARS-CoV-2 Infects Cells Could Speed Up Discovery of COVID-19 Treatments
AI-Based Digital Biomarker Could Assist in Early Intervention in High-Risk COVID-19 Patients
Common Allergy Nasal Spray Medication Shows Potent Efficacy Against SARS-CoV-2
Experimental Cancer Drug Inhibits SARS-CoV-2 Virus from Infecting Cells and Replicating
Dual Bronchodilator and Anti-Inflammatory COPD Drug Offers Potential for COVID-19 Treatment
Ortho Awarded BARDA Contract to Accelerate Development of SARS-CoV-2 Antigen Test
Menarini Diagnostics Launches New SARS-CoV-2 Antigen Test That Also Measures Viral Load
Experimental Drug Blocks SARS-CoV-2 from Entering Lung Cells
Roche’s Actemra for Rheumatoid Arthritis Reduces Need for Mechanical Ventilation in Hospitalized COVID-19 Patients
Potential New Drug Could Reduce Cellular Stress from SARS-CoV-2 Infection in COVID-19 Patients
Snibe Diagnostic’s Maglumi 2019-nCoV IgM/IgG Test Granted FDA Emergency Use Authorization
Rapid 90-Minute COVID-19 Test Shows High Accuracy in New Study
Roche Launches New Quantitative Antibody Test to Measure SARS-CoV-2 Antibodies
Abbott Reissued FDA Emergency Use Authorization for ID Now COVID-19 Test
